What do systematic reviews say?

Intermittent use of iron supplements vs placebo or no intervention

• Intermittent iron supplementation for improving nutrition and development in children under 12 years of age 2011 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Continuous vs Intermittent Antibiotic Infusions

Continuous showed no clear difference in all‐cause mortality compared with intermittent Antibiotic Infusions (moderate certainty).

• Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections 2013 · Cochrane Headline outcomes only
  RR 0.89 [0.67, 1.2]
  19 studies · 1241 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in mortality: all‐cause deaths (moderate certainty).

• Exercise for intermittent claudication 2017 · Cochrane Headline outcomes only
  RR 0.92 [0.39, 2.17]
  5 studies · 540 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in all‐cause mortality (low certainty).

• Intermittent preventive treatment for malaria in infants 2021 · Cochrane Headline outcomes only
  Risk ratio 0.17 [0.01, 4.06]
  1 study · 147 participants
  Low

Intervention not reported

The intervention showed no clear difference in all‐cause mortality (moderate certainty).

• Intermittent preventive treatment for malaria in infants 2021 · Cochrane Headline outcomes only
  Risk ratio 0.83 [0.36, 1.89]
  1 study · 676 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in all‐cause mortality (moderate certainty).

• Intermittent preventive treatment for malaria in infants 2021 · Cochrane Headline outcomes only
  Risk ratio 0.93 [0.74, 1.15]
  9 studies · 14588 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in all‐cause mortality (moderate certainty).

• Intermittent preventive treatment for malaria in infants 2021 · Cochrane Headline outcomes only
  Risk ratio 1.21 [0.58, 2.55]
  1 study · 684 participants
  Moderate

IF vs CER (short term)

The review found no eligible studies for this question.

• Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

IF vs CER (medium term)

The review found no eligible studies for this question.

• Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

IF vs ad libitum (short term)

The review found no eligible studies for this question.

• Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Continuous glucose monitoring system vs intermittent modalities

It is very uncertain whether summary of findings table ‐ Continuous glucose monitoring (CGM) changes death during initial hospitalization (all‐cause mortality) compared with intermittent modalities (very low certainty).

• Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
  RR 0.59 [0.16, 2.13]
  2 studies · 230 participants
  Very low